NCT01296230终止不适用
Varicocelectomy: Can Sex-hormones Predict Improvements in Semen Quality?
Copenhagen University Hospital at Herlev4 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 3
- 试验地点
- 4
- 主要终点
- Change in semen parameters
研究概览
简要总结
The purpose of this study is to determine if the pre-operative levels of sex-hormones can be used to identify the varicocele patients who can expect improvements in their semen parameters following varicocelectomy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Varicocele (grade 1-3) and surgery planned for this condition
- •At least 18 years of age
排除标准
- •Fever within 3 months before the first semen sample
- •Malformations of the uro-genital tract
- •Karyotype other than 46, XY or Y micro deletions
- •Endocrine disease
- •Chronic disease
- •Medications which reduce semen quality
- •Epididymitis within 6 months before surgery
结局指标
主要结局
Change in semen parameters
时间窗: February 2017 (anticipated duration of the study)
次要结局
- Change in hormone levels(February 2017 (anticipated end of the study))
研究者
研究点 (4)
Loading locations...
相似试验
已完成
4 期
Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic FloorPelvic Organ ProlapseMenopauseNCT01778985University of Texas Southwestern Medical Center30
已完成
4 期
Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian FailurePremature Ovarian FailureNCT00732693University of Edinburgh42
已完成
不适用
Hormonal Predictors of Oncologic SurgeryHypogonadismNCT02471157Weill Medical College of Cornell University200
Unknown
2 期
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsArthralgiaBreast CancerOsteoporosisNCT00497458Havah Therapeutics Pty Ltd90
进行中（未招募）
不适用
Preoperative hormone therapy for pre- and postmenopausal women with ER positive breast cancer: A double blind randomized parallel group phase II trial, comparing the effect of 2 weeks of preoperative Estetrol with placebo - Preoperative estetrolbreast cancerEUCTR2006-006542-34-ATPantarhei Bioscience B.V.